Benzyldimethyl(octadecyl)ammonium chloride

Endpoint summary

Key value for chemical safety assessment

Effects on fertility

Description of key information

Based on the results of the read across study, the test substance, C18 ADBAC, is considered not to pose reproductive or development concern up to 2,000 ppm (i.e., equivalent to 30.5 to 50.5 mg a.i./kg bw/day and 48 to 61.5 mg a.i./kg bw/day for the F0 and F1 generation respectively).

Link to relevant study records

Reference

Endpoint:

two-generation reproductive toxicity

Type of information:

read-across from supporting substance (structural analogue or surrogate)

Adequacy of study:

key study

Study period:

2008

Reliability:

2 (reliable with restrictions)

Rationale for reliability incl. deficiencies:

guideline study

Remarks:

KL2 due to RA

Justification for type of information:

Refer to the section 13 of IUCLID dataset for details on the read across justification. The algae study with the read across substance is considered sufficient to fulfil the information requirements as further explained in the provided endpoint summary.

Reason / purpose for cross-reference:

read-across source

Qualifier:

according to guideline

Guideline:

OECD Guideline 416 (Two-Generation Reproduction Toxicity Study)

Deviations:

no

GLP compliance:

yes

Limit test:

no

Species:

rat

Strain:

Sprague-Dawley

Sex:

male/female

Route of administration:

oral: feed

Analytical verification of doses or concentrations:

not specified

Duration of treatment / exposure:

- Exposure period: about 18 wk.
P0 and P1:
Premating exposure period (males): 10 wk.
Premating exposure period (females): 10 wk.
- Duration of test: P0 pre-mating 10 wk, until F2 weaning.

Frequency of treatment:

Continuously

Details on study schedule:

Groups of 25 male and 25 female Sprague-Dawley rats were administered the test substance (purity 49.9%) at levels of 0, 500, 2000 or 4000 ppm in their diet over a period of 10 wk before mating, 2 wk during mating, and until after weaning of the pups (total period 18 wk). From every litter one or two pups were selected to again obtain 25 animals per sex and dose group for the F1 generation. These animals were similarly treated as the parent (P1) animals throughout premating, mating, pregnancy until sacrifice, after weaning of F2 progeny.

Remarks:

Doses / Concentrations:
1000, 2000 and 4000 ppm of test substance

No. of animals per sex per dose:

25

Control animals:

yes, concurrent vehicle

Parental animals: Observations and examinations:

- Examination of P0 and P1 generation:
Clinical signs and mortality were checked daily. Food consumption and body weight were recorded at designated intervals. Males and females were paired for a 2-wk period, until mating was obtained. The P1 females were allowed to deliver normally, and rear their progeny. Pregnancy and litter parameters were recorded.
- During lactation, the pups (F1 generation) were observed daily for survival and clinical signs; body weight was recorded at designated intervals; the sex-ratio was recorded. On Day 4 post-partum, the size of each litter was adjusted to obtain eight pups per litter (four males and four females).
- Reflex development was assessed at designated time-points.

Sperm parameters (parental animals):

Epididymal and testicular sperm parameters were evaluated for both P0 and P1 males.

Litter observations:

Examination of F1/P1 generation:
- On Day 22 post-partum, one male and one female pup per litter were selected to constitute the F1/P1 generation, which comprised 25 males and 25 females per group. The F1/P1 animals were observed daily for clinical signs and mortality. Body weight and food consumption were recorded once a week. Sexual development of both males and females was assessed.
- Neurobehavioural tests were conducted at designated intervals to assess auditory and visual functions. Spontaneous locomotor activity was also evaluated when the animals were between 7 and 8 wk old.
- After sexual maturity, F1 male and F1 female animals were paired. The F1 females were allowed to deliver normally, and rear their progeny. Pregnancy and litter parameters were recorded. During lactation, the pups (F2 generation) were observed daily for survival and clinical signs; body weight was recorded at designated intervals; the sex-ratio was recorded. On day 4 post-partum, the size of each litter was adjusted to obtain eight pups per litter (four males and four females).
- Reflex development was assessed at designated time-points.

Postmortem examinations (parental animals):

Terminal examination of P0 and P1 animals:
- After weaning of their respective progeny, P0 and P1 parent males and females were sacrificed. Designated organs were weighed for P0 and P1 parents, as well as brain, spleen and thymus of one pup per sex per litter of each generation.
- Epididymal and testicular sperm parameters were evaluated for both P0 and P1 males.
- A macroscopic post-mortem examination was performed on all P0 and P1 parent males and females. Any pups which died or were killed prematurely during the lactation period were also submitted for a macroscopic post-mortem examination. Macroscopic lesions, reproductive organs, adrenals and pituitary glands were sampled in all parent animals. A microscopic examination was performed on macroscopic lesions, reproductive organs, adrenals, and pituitary glands of all P0 and P1 parents of the control and high dose groups.
- Particularly detailed histopathological examinations were performed for the ovaries and the testes.

Postmortem examinations (offspring):

- A macroscopic post-mortem examination was performed on three pups per sex and per litter of each P0 and P1 (F1 and F2 generation) females killed at weaning. Any pups which died or were killed prematurely during the lactation period were also submitted for a macroscopic post-mortem examination. In all pups, the macroscopic lesions were preserved.

Clinical signs:

no effects observed

Dermal irritation (if dermal study):

not examined

Mortality:

no mortality observed

Body weight and weight changes:

effects observed, treatment-related

Description (incidence and severity):

- At 4000 ppm, a slightly lower mean body weight gain was recorded during most of the dosing period in both parental males and females (and was associated with reduced liver weights).
- At 2000 and 500 ppm, a marginally to slightly lower body weight gain was noted over all the dosing period for the males.

Food consumption and compound intake (if feeding study):

effects observed, treatment-related

Description (incidence and severity):

- At 4000 ppm, a slightly to moderately lower mean food consumption was recorded during most of the dosing period in both parental males and females.
- At 2000 and 500 ppm, a marginally to slightly lower mean food consumption was noted over all the dosing period for the males.

Food efficiency:

not examined

Water consumption and compound intake (if drinking water study):

not examined

Ophthalmological findings:

not examined

Haematological findings:

not examined

Clinical biochemistry findings:

not examined

Urinalysis findings:

not examined

Behaviour (functional findings):

not examined

Immunological findings:

not examined

Organ weight findings including organ / body weight ratios:

effects observed, treatment-related

Histopathological findings: non-neoplastic:

no effects observed

Description (incidence and severity):

- At 4000 and 2000 ppm, no effects were noted at histopathological examination of sexual organs.

Histopathological findings: neoplastic:

not examined

Reproductive function: oestrous cycle:

not examined

Reproductive function: sperm measures:

no effects observed

Description (incidence and severity):

- At 4000 and 2000 ppm, no effects were noted on sperm parameters.

Reproductive performance:

no effects observed

Description (incidence and severity):

- At 4000 ppm, slightly lower pup body weight was observed (with lower spleen weights).
- At 2000 ppm, no effects were observed on parental fertility as assessed by normal mating, gestation and delivery.
- At 500 ppm, no effects were noted on mating, fertility, gestation, fecundity or delivery of either generation or on development of their progeny.

As lower food consumption is known to occur due to palatability of compound. As no other substance related effects were seen than can be attributed to lower food intake, the level of 500 ppm test substance in the diet, corresponding to 16-25 mg/kg bw/day, should be regarded as NOAEL for P0 and P1generation.

Key result

Dose descriptor:

NOAEL

Remarks:

systemic toxicity

Effect level:

500 ppm

Based on:

test mat.

Sex:

male/female

Basis for effect level:

body weight and weight gain

food consumption and compound intake

organ weights and organ / body weight ratios

gross pathology

Remarks on result:

other: the effect level ranged from 16 to 25 mg/kg bw/day

Key result

Dose descriptor:

NOAEL

Remarks:

reproductive toxicity

Effect level:

2 000 ppm

Based on:

test mat.

Sex:

male/female

Basis for effect level:

reproductive performance

Remarks on result:

other: dose range from 61 to 101 mg/kg bw/day

Key result

Critical effects observed:

yes

Lowest effective dose / conc.:

4 000 ppm

System:

other: reproductive performance

Treatment related:

yes

Dose response relationship:

yes

Clinical signs:

no effects observed

Dermal irritation (if dermal study):

not examined

Mortality:

no mortality observed

Body weight and weight changes:

effects observed, treatment-related

Description (incidence and severity):

- At 4000 ppm, a slightly to moderately lower mean body weight gain was recorded during most of the dosing period in both parental males and females (and was associated with reduced liver weights).
- At 2000 ppm, a marginally to slightly lower mean body weight gain was noted.
- At 500 ppm, a marginally to slightly lower mean body weight gain was observed in both sexes. This was associated with lower liver weights of parental males and females.

Food consumption and compound intake (if feeding study):

effects observed, treatment-related

Description (incidence and severity):

- At 4000 ppm, a slightly to moderately lower mean food consumption was recorded during most of the dosing period in both parental males and females.
- At 2000 and 500 ppm, a marginally to slightly lower mean food consumption was noted over all the dosing period in both sexes.

Food efficiency:

not examined

Water consumption and compound intake (if drinking water study):

not examined

Ophthalmological findings:

not examined

Haematological findings:

not examined

Clinical biochemistry findings:

not examined

Urinalysis findings:

not examined

Behaviour (functional findings):

not examined

Immunological findings:

not examined

Organ weight findings including organ / body weight ratios:

effects observed, treatment-related

Description (incidence and severity):

- At 4000 ppm, reduced liver weights were observed.
- At 2000 and 500 ppm, lower liver weights in parental animals were recorded.

Gross pathological findings:

effects observed, treatment-related

Description (incidence and severity):

- At 4000 ppm, necropsy of these animals revealed dilation of the cecum, colon or ileum in some animals (more marked in F0 parents).
- At 2000 ppm, necropsy of parents revealed dilatation of the cecum in a single animal. 

Neuropathological findings:

not examined

Histopathological findings: non-neoplastic:

no effects observed

Description (incidence and severity):

- At 4000 and 2000 ppm, no effects were noted at histopathological examination of sexual organs.

Histopathological findings: neoplastic:

not examined

Reproductive function: sperm measures:

no effects observed

Description (incidence and severity):

- At 4000 and 2000 ppm, no effects were noted on sperm parameters.

Description (incidence and severity):

- At 4000 ppm, slightly lower pup body weight was observed for each progeny and was associated, for the F2 generation pups, with a reduction in litter size (as a consequence of lower number of implantation sites of P1 females) and a delay in sexual development. Lower spleen weights were also noted for each progeny.
- At 2000 ppm, no effects were noted on parental fertility as assessed by normal mating, gestation and delivery.
- At 500 ppm, no effects were noted on mating, fertility, gestation, fecundity or delivery and development of their progeny.

As lower food consumption is known to occur due to palatability of compound. As no other substance related effects were seen than can be attributed to lower food intake, the level of 500 ppm test substance in the diet, corresponding to 16-25 mg/kg bw/day, should be regarded as NOAEL for P0 and P1generation.

Key result

Dose descriptor:

NOAEL

Remarks:

systemic toxicity

Effect level:

500 ppm

Based on:

test mat.

Sex:

male/female

Basis for effect level:

body weight and weight gain

food consumption and compound intake

organ weights and organ / body weight ratios

gross pathology

Remarks on result:

other: the effect level ranged from 16 to 25 mg/kg bw/day

Key result

Dose descriptor:

NOAEL

Remarks:

reproductive toxicity

Effect level:

2 000 ppm

Based on:

test mat.

Sex:

male/female

Basis for effect level:

body weight and weight gain

food consumption and compound intake

organ weights and organ / body weight ratios

gross pathology

Remarks on result:

other: dose range from 61 to 101 mg/kg bw/day

Key result

Critical effects observed:

yes

Lowest effective dose / conc.:

4 000 ppm

System:

other: reproductive performance

Treatment related:

yes

Dose response relationship:

yes

Clinical signs:

not examined

Dermal irritation (if dermal study):

not examined

Mortality / viability:

mortality observed, treatment-related

Description (incidence and severity):

- At 4000 ppm, the litter size at birth was reduced. 

Body weight and weight changes:

effects observed, treatment-related

Description (incidence and severity):

- At 4000 ppm, slightly reduced pup body weight was observed. Pup weight gain was also slightly lower during lactation.

Food consumption and compound intake (if feeding study):

not examined

Food efficiency:

not examined

Water consumption and compound intake (if drinking water study):

not examined

Ophthalmological findings:

not examined

Haematological findings:

not examined

Clinical biochemistry findings:

not examined

Urinalysis findings:

not examined

Sexual maturation:

no effects observed

Organ weight findings including organ / body weight ratios:

effects observed, treatment-related

Description (incidence and severity):

- At 4000 ppm, lower spleen weights were noted.
- At 2000 ppm, except for a marginally lower spleen weight of the progeny, no other effects were noted on their development.

Gross pathological findings:

no effects observed

Histopathological findings:

no effects observed

Behaviour (functional findings):

not examined

Developmental immunotoxicity:

not examined

Key result

Dose descriptor:

NOAEL

Remarks:

general toxicity

Generation:

F1

Effect level:

2 000 ppm

Based on:

test mat.

Sex:

male/female

Basis for effect level:

body weight and weight gain

organ weights and organ / body weight ratios

Key result

Dose descriptor:

NOAEL

Remarks:

developmental toxicity

Generation:

F1

Effect level:

2 000 ppm

Based on:

test mat.

Sex:

male/female

Basis for effect level:

body weight and weight gain

organ weights and organ / body weight ratios

Key result

Critical effects observed:

yes

Lowest effective dose / conc.:

4 000 ppm

System:

other: body weight and organs weight

Organ:

spleen

Treatment related:

yes

Dose response relationship:

yes

Clinical signs:

not examined

Dermal irritation (if dermal study):

not examined

Mortality / viability:

mortality observed, treatment-related

Description (incidence and severity):

- At 4000 ppm, the litter size at birth were reduced (as a consequence of lower number of implantation sites of F1 parent females).
- At 2000 ppm, no effects were seen in F2 offspring regarding pup survival until weaning.

Body weight and weight changes:

effects observed, treatment-related

Description (incidence and severity):

- At 4000 ppm, slightly lower pup body weight was observed. The pup weight gain was slightly reduced during lactation, 
- At 2000 ppm, no effects were seen regarding pup development.

Food consumption and compound intake (if feeding study):

not examined

Food efficiency:

not examined

Water consumption and compound intake (if drinking water study):

not examined

Ophthalmological findings:

not examined

Haematological findings:

not examined

Clinical biochemistry findings:

not examined

Urinalysis findings:

not examined

Sexual maturation:

effects observed, treatment-related

Organ weight findings including organ / body weight ratios:

effects observed, treatment-related

Description (incidence and severity):

- At 4000 ppm, lower spleen weights were noted.
- At 2000 ppm, except for a marginally lower spleen weight, no other effects were noted on their development.

Gross pathological findings:

effects observed, treatment-related

Description (incidence and severity):

At 4000 ppm, dilatation of the caecum with faeces was observed in 4/25 males and 2/25 females.
At 2000 ppm, no effects were seen regarding pup development and after sacrifice at weaning.

Histopathological findings:

not examined

Behaviour (functional findings):

not examined

Developmental immunotoxicity:

not examined

Key result

Dose descriptor:

NOAEL

Remarks:

general / developmental toxicity

Generation:

F2

Effect level:

2 000 ppm

Based on:

test mat.

Sex:

male/female

Basis for effect level:

sexual maturation

mortality

body weight and weight gain

organ weights and organ / body weight ratios

gross pathology

Key result

Dose descriptor:

LOAEL

Remarks:

general / developmental toxicity

Generation:

F2

Effect level:

4 000 ppm

Based on:

test mat.

Sex:

male/female

Basis for effect level:

sexual maturation

mortality

body weight and weight gain

organ weights and organ / body weight ratios

gross pathology

Key result

Critical effects observed:

yes

Lowest effective dose / conc.:

4 000 ppm

System:

other: spleen weight

Treatment related:

yes

Dose response relationship:

yes

Key result

Reproductive effects observed:

yes

Lowest effective dose / conc.:

2 000 ppm

Treatment related:

yes

Relation to other toxic effects:

reproductive effects as a secondary non-specific consequence of other toxic effects

Dose response relationship:

yes

The mean achieved dosages of the test substance for the dose-levels of 500, 2000 and 4000 ppm of test substance were as follows:
F0 generation
- males (Days 1 to 106): 16, 61 and 123 mg/kg bw/day, respectively,
- females:

during premating period (Days 1 to 71): 19, 74 and 154 mg/kg bw/day, respectively,
    during pregnancy period (Days 0 to 20 p.c.): 18, 69 and 145 mg/kg bw/day, respectively,
    during lactation period (Days 1 to 21 p.p.): 37, 159 and 326 mg/kg bw/day, respectively.
F1 generation
- males (Days 1 to 120): 24, 96 and 202 mg/kg bw/day, respectively,
- females:
    during premating period (Days 1 to 64): 32, 127 and 269 mg/kg bw/day, respectively,
    during pregnancy period (Days 0 to 20 p.c.): 21, 83 and 164 mg/kg bw/day, respectively,
    during lactation period (Days 1 to 21 p.p.): 41, 162 and 323 mg/kg bw/day, respectively.

The actual intake of test substance for both males and females given 500, 2000 and 4000 ppm throughout the study is approximately 16-25, 61-101 and 123-208 mg/kg bw/day, respectively  for the F0 generation and 24-31, 96-123 and 202-252 mg/kg bw/day for the F1 generation.

Conclusions:

Based on the results of the study, the rat NOEL for parental toxicity is considered to be 500 ppm for the male and the female animals. The rat NOEL for mating behaviour, fertility and gestation of each generation and for development, growth and survival of each progeny is established at 2,000 ppm (61 to 101 mg/kg bw/day (nominal) (equivalent to 30.5 to 50.5 mg a.i./kg bw/day and 96 to 123 mg/kg bw/day (nominal) (equivalent to 48 to 61.5 mg a.i./kg bw/day for the F0 and F1 generation respectively))

Executive summary:

A study was conducted to determine the toxicity to reproduction of the read across substance, C12-C16 ADBAC (active: 49.9%), according to OECD Guideline 416, in compliance with GLP. In this two-generation study, the substance was administered in the diet to male and female Sprague Dawley rats at dose levels of 0, 500, 2,000 and 4,000 ppm (purity 49.9%) (corresponding to 0 mg (a.i.)/kg bw/day, 16-25 and 24-31 mg/kg bw/day or 8-12.5 and 12-15.5 mg a.i./kg bw/day in males and females, 61-101 and 96-123 mg/kg bw/day or 30.5-50 and 48 to 61.5 mg a.i./kg bw/day in males and females and 123-208 and 202-252 mg/kg bw/day or 61-104 and 101-126 mg a.i./kg bw/day in males and females, respectively). Doses were administered before and throughout mating and gestation until the end of the lactation period in both P0 and P1 generations. At 2,000 ppm, P0 (males) and P1 (both sexes) showed marginally to slightly lower body weight gains and reduced food consumption. Necropsy of parents of both generations revealed dilatation of the caecum in some animals. This was associated with lower liver weights in parental animals of both generations. At 4,000 ppm, in P0 and P1 generations, number of implantation sites and litter size at birth were reduced. The progenies (F1 and F2) also showed lower pup weights. Pup weight gain was slightly lower during lactation. The weight of the spleen was also reduced. Upon necropsy, dilatation of the caecum with faeces was observed in 4/25 males and 2/25 females in F2. Treatment with the test substance had no effect on mating, fertility and behavioural parameters in P0 and P1 parental Sprague-Dawley rats at treatment levels up to 2,000 ppm. No effect was recorded on litter parameters and on pre- and post-natal development of either generation at 2,000 ppm. Under the conditions of the study, the rat NOEL for parental toxicity was at 500 ppm for the male and the female animals. The rat NOEL for mating behaviour, fertility and gestation of each generation and for development, growth and survival of each progeny was established at 2,000 ppm (61 to 101 mg/kg bw/day (nominal) (equivalent to 30.5 to 50.5 mg a.i./kg bw/day and 96 to 123 mg/kg bw/day (nominal) (equivalent to 48 to 61.5 mg a.i./kg bw/day for the F0 and F1 generation respectively)) (Foulon, 2008). Based on the results of the read across study, similar NOAEL for parental and reproductive/development toxicity can be considered for the test substance, C18 ADBAC.

Effect on fertility: via oral route

Endpoint conclusion:

adverse effect observed

Dose descriptor:

NOAEL

30.5 mg/kg bw/day

Study duration:

subchronic

Species:

rat

Quality of whole database:

Information requirement for this tonnage band is sufficiently met with the available data.

Effect on fertility: via inhalation route

Endpoint conclusion:

no study available

Effect on fertility: via dermal route

Endpoint conclusion:

no study available

Additional information

A study was conducted to determine the toxicity to reproduction of the read across substance, C12-C16 ADBAC (active 49.9%), according to OECD Guideline 416, in compliance with GLP. In this two-generation study, the substance was administered in the diet to male and female Sprague Dawley rats at dose levels of 0, 500, 2,000 and 4,000 ppm (purity 49.9%) (corresponding to 0 mg (a.i.)/kg bw/day, 16-25 and 24-31 mg/kg bw/day or 8-12.5 and 12-15.5 mg a.i./kg bw/day in males and females, 61-101 and 96-123 mg/kg bw/day or 30.5-50 and 48 to 61.5 mg a.i./kg bw/day in males and females and 123-208 and 202-252 mg/kg bw/day or 61-104 and 101-126 mg a.i./kg bw/day in males and females, respectively). Doses were administered before and throughout mating and gestation until the end of the lactation period in both P0 and P1 generations. At 2,000 ppm, P0 (males) and P1 (both sexes) showed marginally to slightly lower body weight gains and reduced food consumption. Necropsy of parents of both generations revealed dilatation of the caecum in some animals. This was associated with lower liver weights in parental animals of both generations. At 4,000 ppm, in P0 and P1 generations, number of implantation sites and litter size at birth were reduced. The progenies (F1 and F2) also showed lower pup weights. Pup weight gain was slightly lower during lactation. The weight of the spleen was also reduced. Upon necropsy, dilatation of the caecum with faeces was observed in 4/25 males and 2/25 females in F2. Treatment with the test substance had no effect on mating, fertility and behavioural parameters in P0 and P1 parental Sprague-Dawley rats at treatment levels up to 2,000 ppm. No effect was recorded on litter parameters and on pre- and post-natal development of either generation at 2,000 ppm. Under the conditions of the study, the rat NOEL for parental toxicity was at 500 ppm for the male and the female animals. The rat NOEL for mating behaviour, fertility and gestation of each generation and for development, growth and survival of each progeny was established at 2,000 ppm (i.e., equivalent to 30.5 to 50.5 mg a.i./kg bw/day and 48 to 61.5 mg a.i./kg bw/day for the F0 and F1 generation respectively) (Foulon, 2008). Based on the results of the read across study, similar NOELs for parental and reproductive/development toxicity can be considered for the test substance, C18 ADBAC.

Effects on developmental toxicity

Effect on developmental toxicity: via oral route

Endpoint conclusion:

no study available

Effect on developmental toxicity: via inhalation route

Endpoint conclusion:

no study available

Effect on developmental toxicity: via dermal route

Endpoint conclusion:

no study available

Justification for classification or non-classification

Based on the results of the read across study, the test substance, C18 ADBAC, is concluded not to warrant classification for reproductive toxicity according to EU CLP criteria (Regulation 1272/2008/EC).